Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Recurrent Ascites
NCT05014594Phase 2Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Sep 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in ascites, sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT05014594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05014594.